You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKesson
Mallinckrodt
Colorcon
McKinsey

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018343


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 018343 describes CAPOTEN, which is a drug marketed by Par Pharm and is included in one NDA. Additional details are available on the CAPOTEN profile page.

The generic ingredient in CAPOTEN is captopril. There are fifteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the captopril profile page.
Summary for 018343
Tradename:CAPOTEN
Applicant:Par Pharm
Ingredient:captopril
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018343
Paragraph IV (Patent) Challenges for 018343
Tradename Dosage Ingredient NDA Submissiondate
CAPOTEN TABLET;ORAL captopril 018343

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 018343

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995   Start Trial   Start Trial
Par Pharm CAPOTEN captopril TABLET;ORAL 018343-005 Jan 17, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Dow
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.